Wang L, Liu L, Zhang Z, Li F, et al. Cost-effectiveness of Sacituzumab Govitecan versus Single-agent Chemotherapy for Patients with Metastatic Triple-Negative Breast Cancer in China. Clin Breast Cancer 2024 Apr 23:S1526-8209(24)00110.
PMID: 38760263